Study: Cai 2026, ERJ Open Research

Race-neutral spirometry reclassification in self-identified Black and White patients

Citation

Cai X, Canaday F, Gao S, Merrell E et al (2026). ERJ Open Research. PubMed id 42741266.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Lung function tests and race correction in spirometry Tier B moderate

    B 6,107 spirometry tests in a 2010 to 2020 retrospective cohort, self-identified Black and White patients (n=6107)

    Retrospective cohort comparing race-specific and GLI-Global interpretation with one-year outcomes.

    Switching to the race-neutral approach reclassified 530 results (9%) for FEV1 and 595 (10%) for FVC. Black patients reclassified as abnormal had higher healthcare use and worse outcomes, including hospitalisation, than those consistently normal; White patients reclassified as normal also had worse outcomes, including higher mortality. The authors say clinical judgment is needed for results near the cut-off.

    As recorded in this card: Cai X, Canaday F, Gao S, Merrell E et al (2026), ERJ Open Research, [primary]

    Note: Single health system, US; the abstract text was cut off before the final limits sentence.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.